Fingerprint
Dive into the research topics of 'Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
Christopher A. Walker, Alexandra N. Spirtos, David S. Miller
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations